Intellipharmaceutics International Incorporation operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Intellipharmaceutics International Incorporation with three other
companies in this sector in Canada:
Acerus Pharmaceuticals Corporation
(2017
sales of 8.35 million Canadian Dollars [US$6.54 million]
),
Pediapharm Inc
(6.21 million Canadian Dollars [US$4.86 million]
), and
IntelGenx Technologies Corp.
(6.73 million Canadian Dollars [US$5.27 million]
).
Sales Analysis.
Intellipharmaceutics International Incorporation reported sales of C$7.17 million (US$5.62 million)
for the
fiscal
year ending
November of 2017.
This
represents
an
increase of 140.9%
versus 2016, when the company's sales were C$2.98 million.